Philadelphia, PA, United States of America

Smithkline Beechman Corporation


USPTO Granted Patents = 7

% Expired Patents = 42.9

Forward Citations = 57

Loading Chart...
Loading Chart...

22 inventors (with patents filed for the assignee):

goldMedal James Francis Callahan (1 out of 64 patents)

silverMedal Jiri Kasparec (1 out of 14 patents)

bronzeMedal Deirdre Mary Bernadette Hickey (1 out of 23 patents)

4.  Colin Houston MacPhee (1 out of 13 patents)

5.  David Graham Tew (1 out of 9 patents)

6.  Domingos J Silva (1 out of 14 patents)

7.  Christopher Donald Southan (1 out of 13 patents)

8.  Israel Simon Gloger (1 out of 7 patents)

9.  Geoffrey Mark Prouse Lawrence (1 out of 3 patents)

10.  Simon Quentyn John Rice (1 out of 4 patents)

11.  Geoffrey Douglas Clarke (1 out of 1 patent)

12.  Melanie Jayne Sammons (1 out of 1 patent)

13.  Mark Wyles (1 out of 1 patent)

14.  William David Steber (1 out of 8 patents)

15.  Ambrish Vyas (1 out of 1 patent)


7 patents:

Company Overview
Smithkline Beecham Corporation is a leading pharmaceutical company dedicated to improving human health. With a focus on research and development, they offer a wide range of innovative products and services to meet the needs of patients worldwide.
Profile summary synthesized from public USPTO records and patent filings.

logo

Company Badge

USPTO Data Jan 1 1976 - Oct 13 2026

7 Patents

#126 in Philadelphia, PA

#1,438 in Pennsylvania

#39,907 in US

Philadelphia, PA (US)
Philadelphia, PA, United States of America
Forward Citations = 57

22 inventors:

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Smithkline Beechman Corporation. Retrieved from https://idiyas.com/company/smithkline-beechman

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…